X
08Jun

FDA Signals a Deliberative Approach to Cannabis at Public Hearing

While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By: Wilson Sonsini Goodrich & Rosati
Source Url: https://www.jdsupra.com/legalnews/fda-signals-a-deliberative-approach-to-46336/

Related

Could Brexit change the landscape of worker status claims?

In the UK, the definition of "worker" includes both employees and anyone else working under a contra...

Read More >

Cheaper Gasoline Prices Means Decrease in Optional Standard Mileage Rates for 2020

The Internal Revenue Service has announced the optional standard mileage rates for computing the ded...

Read More >

[Webinar] 2020 OFCCP Developments: What Federal Contractors Need to Know this Year - January 15th, 1:00 pm ET

In 2019, OFCCP has been very busy increasing its enforcement activities and issuing policy changes. ...

Read More >

UK Supreme Court issues important decision upholding non-compete

The UK Supreme Court has today published its long-awaited judgment in Egon Zehnder Ltd v Tillman. It...

Read More >

Claims For Liquidated Damages Against Subcontractors

Main contractors often make claims against subcontractors for liquidated damages for delay. A questi...

Read More >